Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 31.15%5.74M | 77.93%4.18M | 108.31%2.86M | 9.68%16.17M | 35.71%8.07M | 22.28%4.38M | 20.98%2.35M | -58.09%1.37M | -61.72%14.74M | -79.34%5.95M |
| Net profit before non-cash adjustment | -42.13%1.95M | 0.81%3.12M | 65.70%2.87M | 27.74%11.64M | 395.40%3.45M | 15.40%3.37M | 23.25%3.09M | -42.08%1.73M | -57.54%9.11M | 1,610.90%695.57K |
| Total adjustment of non-cash items | 81.83%1.45M | 301.73%349K | 401.34%747K | -37.72%1.16M | -77.96%383.24K | 16.33%798K | 68.55%-173K | 976.47%149K | -62.63%1.86M | -56.58%1.74M |
| -Depreciation and amortization | -9.55%587K | -3.81%556K | 7.34%614K | 9.34%2.45M | 16.89%653.58K | 17.57%649K | 3.58%578K | -0.35%572K | 9.91%2.24M | 0.96%559.17K |
| -Disposal profit | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| -Net exchange gains and losses | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 | ---15K |
| -Pension and employee benefit expenses | ---- | ---- | --0 | 160.54%30.15K | 939.80%37.15K | ---- | ---- | --0 | -94.33%11.57K | -98.25%3.57K |
| -Other non-cash items | 439.10%841K | 72.44%-207K | 131.44%133K | -234.25%-1.33M | -125.81%-307.49K | 40.54%156K | 32.22%-751K | 28.43%-423K | -114.37%-396.55K | -63.32%1.19M |
| Changes in working capital | 1,025.00%2.34M | 224.52%711K | -49.01%-754K | -10.59%3.37M | 20.76%4.24M | 842.86%208K | -3,072.22%-571K | -265.36%-506K | -68.76%3.77M | -85.80%3.51M |
| -Change in receivables | -231.73%-137K | 164.38%282K | 98.26%-8K | -345.47%-504.59K | -5.60%289.41K | 188.14%104K | -442.19%-438K | -314.41%-460K | -33.69%205.56K | 314.16%306.56K |
| -Change in inventory | -68.78%-319K | 69.77%-159K | 14.77%-75K | -505.47%-99.21K | -13.18%703.79K | 40.57%-189K | -653.68%-526K | 85.43%-88K | 78.06%-16.39K | -26.33%810.61K |
| -Change in payables | 854.27%2.8M | 49.62%588K | -1,697.62%-671K | 10.98%3.98M | 35.62%3.25M | -28.19%293K | 263.07%393K | -95.89%42K | -69.73%3.58M | -89.84%2.4M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 96.68%-38K | 27.58%-743K | 43.55%-551K | -2.15%-3.66M | 4.78%-516.23K | 21.87%-1.14M | 35.71%-1.03M | -5,841.18%-976K | 44.83%-3.58M | 35.59%-542.13K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 76.30%5.71M | 159.88%3.43M | 482.58%2.31M | 12.09%12.51M | 39.77%7.56M | 52.79%3.24M | 284.01%1.32M | -87.97%396K | -65.14%11.16M | -80.66%5.41M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -28.22%-4.02M | 1.30%-2.59M | 4.23%-2.81M | -57.17%-12.41M | -40.93%-3.73M | -35.22%-3.13M | -52.98%-2.62M | -139.77%-2.93M | -42.16%-7.89M | -16.96%-2.64M |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | 0.00%157K | -28.43%146K | -7.11%196K | -36.71%733.91K | -43.69%161.91K | -29.60%157K | -33.98%204K | -37.94%211K | 10.98%1.16M | -16.61%287.51K |
| Investing cash flow | -29.70%-3.86M | -0.99%-2.44M | 4.01%-2.61M | -73.33%-11.67M | -51.26%-3.56M | -42.12%-2.98M | -72.13%-2.42M | -208.28%-2.72M | -49.39%-6.74M | -23.01%-2.36M |
| Financing cash flow | ||||||||||
| Cash dividends paid | 0.00%-3.24M | 0.00%-1K | 0.00%-3.24M | 66.67%-9.73M | 0.00%-3.24M | 75.00%-3.24M | ---1K | 75.00%-3.24M | 25.00%-29.18M | 87.50%-3.24M |
| Cash dividends for minorities | ---- | ---- | --0 | ---1.5M | ---201 | ---- | ---- | ---3K | --0 | --0 |
| Net other fund-raising expenses | ---- | ---- | ---- | ---3.46K | ---458 | --1K | --0 | ---4K | ---- | ---- |
| Financing cash flow | 31.62%-3.24M | 0.00%-1K | 0.12%-3.24M | 61.51%-11.23M | -0.02%-3.24M | 63.45%-4.74M | ---1K | 74.97%-3.25M | 33.80%-29.18M | 89.20%-3.24M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.23%31.81M | -21.12%30.82M | -23.02%34.36M | -35.67%44.64M | -25.28%33.49M | -34.27%37.97M | -33.59%39.07M | -35.67%44.64M | -19.43%69.39M | -39.20%44.82M |
| Current changes in cash | 68.82%-1.4M | 190.68%993K | 36.34%-3.55M | 58.01%-10.4M | 486.71%747.88K | 65.39%-4.48M | -3.40%-1.1M | 47.27%-5.57M | -49.32%-24.76M | 95.15%-193.4K |
| Effect of exchange rate changes | ---- | ---- | --0 | 1,718.80%122.02K | 1,718.80%122.02K | ---- | ---- | --0 | 104.35%6.71K | 101.99%6.71K |
| End cash Position | -9.19%30.41M | -16.23%31.81M | -21.12%30.82M | -23.02%34.36M | -23.02%34.36M | -25.28%33.49M | -34.27%37.97M | -33.59%39.07M | -35.67%44.64M | -35.67%44.64M |
| Free cash flow | 1,538.83%1.69M | 165.33%848K | 80.31%-499K | -96.93%100.2K | 38.65%3.83M | 151.76%103K | 5.12%-1.3M | -222.47%-2.53M | -87.65%3.26M | -89.25%2.76M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.